MELISSA WILLIAMS: Open Payments
NPI 1336548866 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,044 in 116 payments from 20 companies in 2025. Trend: 2023 $1,407 · 2024 $2,287 · 2025 $2,044
Food & beverage: $1,959Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $394 |
| Janssen Biotech, Inc. | 34 | $279 |
| Organon LLC | 12 | $251 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $209 |
| Lilly USA, LLC | 4 | $104 |
| Arcutis Biotherapeutics, Inc. | 5 | $92 |
| Regeneron Healthcare Solutions, Inc. | 3 | $80 |
| PFIZER INC. | 4 | $76 |
| GENZYME CORPORATION | 3 | $71 |
| Galderma Laboratories, L.P. | 4 | $65 |
Products named: TREMFYA, RINVOQ, SKYRIZI, VTAMA, DUPIXENT, Zoryve, EBGLYSS, CIBINQO.
Industry payments across AL — which companies pay providers there.
